Canada Pension Plan Investment Board grew its stake in shares of Genpact Limited (NYSE:G - Free Report) by 33.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 103,100 shares of the business services provider's stock after purchasing an additional 26,100 shares during the period. Canada Pension Plan Investment Board owned approximately 0.06% of Genpact worth $4,428,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also recently made changes to their positions in the company. SRH Advisors LLC bought a new position in shares of Genpact during the 4th quarter valued at approximately $26,000. Atlas Capital Advisors Inc. grew its position in Genpact by 55.8% during the fourth quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock worth $26,000 after buying an additional 216 shares in the last quarter. Manchester Capital Management LLC purchased a new position in Genpact during the fourth quarter worth about $38,000. Smartleaf Asset Management LLC grew its position in Genpact by 416.5% during the fourth quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider's stock worth $41,000 after buying an additional 783 shares in the last quarter. Finally, UMB Bank n.a. grew its position in Genpact by 55.7% during the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock worth $52,000 after buying an additional 433 shares in the last quarter. Institutional investors and hedge funds own 96.03% of the company's stock.
Genpact Stock Performance
Shares of Genpact stock traded up $0.22 during trading on Monday, hitting $48.26. 1,102,381 shares of the company's stock traded hands, compared to its average volume of 1,332,923. Genpact Limited has a 1 year low of $30.38 and a 1 year high of $56.76. The business has a 50-day simple moving average of $49.76 and a 200-day simple moving average of $46.42. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85. The stock has a market capitalization of $8.48 billion, a P/E ratio of 16.99, a PEG ratio of 1.84 and a beta of 1.06.
Genpact (NYSE:G - Get Free Report) last posted its earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. As a group, analysts forecast that Genpact Limited will post 3.21 EPS for the current year.
Genpact Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th were given a dividend of $0.17 per share. The ex-dividend date of this dividend was Tuesday, March 11th. This represents a $0.68 annualized dividend and a dividend yield of 1.41%. This is a positive change from Genpact's previous quarterly dividend of $0.15. Genpact's dividend payout ratio is presently 23.94%.
Insider Activity
In other Genpact news, CEO Balkrishan Kalra sold 13,600 shares of the stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total transaction of $664,904.00. Following the completion of the sale, the chief executive officer now directly owns 310,246 shares of the company's stock, valued at $15,167,926.94. This trade represents a 4.20 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 2.80% of the company's stock.
Analysts Set New Price Targets
Several equities analysts recently commented on the company. Needham & Company LLC boosted their target price on Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a research report on Friday, February 7th. Jefferies Financial Group raised Genpact from a "hold" rating to a "buy" rating and increased their target price for the stock from $44.00 to $55.00 in a research report on Tuesday, January 21st. Mizuho increased their target price on Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a research report on Monday, February 10th. Finally, TD Cowen raised Genpact from a "hold" rating to a "buy" rating and raised their price objective for the company from $45.00 to $60.00 in a research report on Friday, February 7th. Five equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, Genpact presently has a consensus rating of "Hold" and an average target price of $50.38.
View Our Latest Stock Report on G
About Genpact
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Stories

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.